O’FALLON, Mo.--(BUSINESS WIRE)--Synergetics USA, Inc. (NASDAQ: SURG) announced today that Jerry Malis, its director and Chief Scientific Officer, and Donna Scheller, the wife of Gregg Scheller, its director and Chief Executive Officer, have adopted prearranged Rule 10b5-1 stock trading plans allowing them to sell a portion of their Company stock over time as part of their tax and estate planning. The stock trading plans were adopted in accordance with the guidelines specified by Rule 10b5-1 under the Securities Exchange Act of 1934 and Synergetics USA’s policies regarding stock transactions.
